BrightInsight CEO Kal Patel M.D. discusses the future of regulated digital health for biopharma and medtech  [Sponsored]


In order to benefit from the Virtual1Care trend, pharma and medtech companies must ensure that their digital health tools, wrapped around a drug or device, comply with evolving regulations.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.